Navigation Links
Accumetrics, Inc. Announces Distribution Channels in Israel and Cyprus
Date:6/9/2009

SAN DIEGO, June 9 /PRNewswire/ -- Accumetrics, Inc. announces today it has signed new distribution agreements for its VerifyNow(R) System in both Israel and Cyprus. Medtechnica, Ltd. will oversee distribution of all VerifyNow products in Israel, while Z.S. Curemed, Ltd. will be the sole distribution channel in Cyprus. These distribution agreements continue to expand Accumetrics' reach in both scope and geography, and add to the growing numbers of countries outside of the United States and Europe where physicians have access to the VerifyNow System.

The VerifyNow System assesses response to antiplatelet therapies, such as aspirin, Plavix(R) and GP IIb/IIIa inhibitors. As response to these drugs varies, the tests help physicians ensure their patients on antiplatelet medications are receiving the optimal benefit.

"We're extremely excited to see distribution of our VerifyNow System reach Israel and Cyprus. We have chosen these partners based on their demonstrated expertise and knowledge of our markets in their respective territories," said Timothy I. Still, President and CEO of Accumetrics. "These partnerships continue to emphasize our focus on expanding our global distribution channels, and support our vision of providing physicians worldwide access to critical information for managing their cardiovascular patients on antiplatelet therapies."

About Accumetrics (www.accumetrics.com)

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including EC-cleared product for prasugrel and FDA-cleared products for aspirin, Plavix, ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of sanofi-aventis.

About Medtechnica, Ltd.

Founded in 1958, Medtechnica, Ltd. has become one of the largest medical equipment suppliers in Israel. Medtechnica is the sole distributor, in Israel, of leading international manufacturers of medical equipment, including Phillips Medical Systems, Olympus Medical, Maquet, 3M Medical and among others.

About Z.S. Curemed, Ltd.

Established in 2001 in Cyprus, Curemed has grown to become one of the leading companies in the sectors of Interventional Cardiology and Intensive Care. Curemed focuses on promotion, sales and support of innovative Interventional Cardiology and Intensive Care devices to Public and Private Hospitals in Cyprus. Curemed conforms to EN ISO 9001: 2008.

    CONTACT:
    Jules Abraham
    Lippert/Heilshorn & Associates
    212-838-3777
    jabraham@lhai.com

    Timothy I. Still
    President and CEO
    Accumetrics
    press@accumetrics.com


'/>"/>
SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial
2. Accumetrics, Inc. Announces United Kingdom Distribution Agreement With ELITech UK Limited
3. Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
4. Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.
5. Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
6. Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit
7. Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of Solid Tumors
8. Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging
9. Life Spine Announces Appointment of Todd Fanning as Vice President of Sales
10. CareFusion Announces Board of Directors, Progress on Alaris Consent Decree
11. ThinIdentity(TM) Announces Two New Board Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Houston, TX (PRWEB) , ... February 27, 2017 ... ... the 75,000 customer threshold mark last week. In addition, Discount Power's RCE (Residential ... Volterra Energy LLC in March 2014. The company had 800 customers and 2,250 ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of Kim Jong-nam, ... nerve agents and the deadly use of chemical weapons. Many questions exist about the ... small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical Institute, ...
(Date:2/26/2017)... ... 2017 , ... IndustryArchive.Org . is announcing a new way for B2B ... now only pay for B.A.N.T. quality sales leads based on the Sellers decision to ... new reality that B2B buyers are controlling the sales process via the Internet and ...
(Date:2/25/2017)... ... ... FCPX users now have the ability to sharpen a desired color range ... have total control over sharpening amount, sharpening radius, threshold, horizontal sharpening, vertical sharpening, and ... can visually see the color range effected with ease all within Final Cut ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis ... University of Pittsburgh points to eight genes that may explain why susceptibility to one ... the results of a study published today in the journal npj Schizophrenia. , ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... N.J. , Feb. 27, 2017  Interpace Diagnostics ... that provides clinically useful molecular diagnostic tests and pathology ... be presented at the upcoming United States ... being held March 4-10, 2017 in San ... reflect a review of data from the Company,s extensive ...
(Date:2/27/2017)... , Feb. 27, 2017  International Biophysics Corporation, a ... , today announced a 34% revenue growth in 2016 ... increase in unit sales.  This growth was fueled by its ... in addition to the expansion of its global sales of ... International Biophysics, CEO, "As we enter our 25 th ...
(Date:2/27/2017)... Calif. , Feb. 27, 2017   Vitasome ... line of nutritional supplements using its groundbreaking new liposome ... 90 percent of potency through digestion per Physician,s ... supplements solve the problem of nutritional waste and are ... degradation during digestive processes Improve bioavailability ...
Breaking Medicine Technology: